NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity
NEXGEL, Inc. has rescheduled its Q4 and full-year 2025 financial results conference call to April 8, 2026, to provide shareholders with more detailed information about its proposed transaction with Celularity Inc. The company concurrently filed its 2025 Annual Report with the SEC. NEXGEL specializes in healthcare, beauty, and OTC hydrogel products …